- In February 2024, BioNTech SE and Autolus Therapeutics plc have partnered to advance autologous CAR-T cell therapies toward commercialization, subject to regulatory approval. This collaboration will strengthen their position in the cell therapy market and accelerate the development of innovative cancer treatments
